The role of cardiac biomarkers elevation in intermediate-high risk pulmonary embolism

被引：0
|
作者：
Ines Pires, M. Maria [1 ]
Santos, J. M. [1 ]
Goncalves, M. L. [1 ]
Correia, J. [1 ]
Neto, V. [1 ]
Antunes, H. [1 ]
Costa Cabral, J. [1 ]
Almeida, I. [1 ]
机构：
[1] Hosp Sao Teotonio, Cardiol, Viseu, Portugal
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1418
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [31] INTERMEDIATE-HIGH RISK PULMONARY EMBOLISM AND RIGHT HEART THROMBI-IN-TRANSIT: ATHERAPEUTIC CHALLENGE?
    Greco, C.
    Albanese, M.
    Miccoli, M.
    Mangia, F.
    Panzera, D.
    Nicolardi, S.
    Gilmanov, D.
    Cucurachi, M.
    Zaccaria, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0C) : C28 - C28
  • [32] Prognostic impact of the e-TAPSE ratio in intermediate-high risk pulmonary embolism patients
    Marco Zuin
    Claudio Bilato
    Amedeo Bongarzoni
    Pietro Zonzin
    Franco Casazza
    Loris Roncon
    The International Journal of Cardiovascular Imaging, 2024, 40 : 467 - 476
  • [33] Single-center experience on percutaneous rheolytic thrombectomy in patients with pulmonary embolism at high risk or intermediate-high risk
    Akbal, Ozgur
    Kaymaz, Cihangir
    Hakgor, Aykun
    Tanyeri, Seda
    Tokgoz, Hacer
    Keskin, Berhan
    Karagoz, Ali
    Turkday, Sevim
    Tanboga, Ibrahim
    Dogan, Cem
    Acar, Rezzan Deniz
    Bayram, Zubeyde
    Ozdemir, Nihal
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B134 - B134
  • [34] SHORT TERM OUTCOMES OF RESCUE RE-PERFUSION THERAPY IN HIGH AND INTERMEDIATE-HIGH RISK PULMONARY EMBOLISM, VIA A PULMONARY EMBOLISM RESPONSE TEAM
    Brennan, A.
    Cho, J.
    Chien, J.
    RESPIROLOGY, 2021, 26 : 66 - 66
  • [35] Case Series of Patients With Intermediate-High Risk Pulmonary Embolism in the Setting of Trauma Undergoing Mechanical Thrombectomy
    Kumar, Gautam
    Brown, Matthew J.
    Smith, Emily
    Benjamin, Elizabeth
    Mcdaniel, Michael
    Sachdeva, Rajesh
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2023, 54 : 63 - 66
  • [36] Continuous low-dose thrombolysis in patients with intermediate-high risk pulmonary embolism: A retrospective analysis
    Droppa, Michal
    Zdanyte, Monika
    Henes, Jessica Kristin
    Gawaz, Meinrad
    Borst, Oliver
    Rath, Dominik
    THROMBOSIS RESEARCH, 2023, 226 : 33 - 35
  • [37] In-hospital and short-term predictors of mortality in patients with intermediate-high risk pulmonary embolism
    Gok, Gulay
    Karadag, Mehmet
    Cinar, Tufan
    Nurkalem, Zekeriya
    Duman, Dursun
    JOURNAL OF CARDIOVASCULAR AND THORACIC RESEARCH, 2020, 12 (04) : 321 - 327
  • [38] Intermediate-high risk pulmonary embolism: how to predict which patients may benefit from fibrinolysis?
    Antunes, H.
    Abreu, L.
    Gil, J.
    Goncalves, M. L.
    Marmelo, B.
    Pires, I.
    Moreira, D.
    Almeida, I.
    Correia, M.
    Cabral, C.
    EUROPEAN HEART JOURNAL, 2017, 38 : 740 - 740
  • [39] Single-center experience on ultrasound-facilitated thrombolysis in patients with pulmonary embolism at high risk or intermediate-high risk
    Kaymaz, C.
    Akbal, O.
    Yilmaz, F.
    Ozturk, S.
    Tanboga, I.
    Turkday, S.
    Hakgor, A.
    Poci, N.
    Safak, A.
    Yildiz, C.
    Tokgoz, H.
    Ozdemir, N.
    EUROPEAN HEART JOURNAL, 2016, 37 : 755 - 755
  • [40] Comparison of clinical scores for identification of patients with pulmonary embolism at intermediate-high risk of adverse clinical outcome: the prognostic role of plasma lactate
    Vanni, Simone
    Nazerian, Peiman
    Bova, Carlo
    Bondi, Ernesta
    Morello, Fulvio
    Pepe, Giuseppe
    Paladini, Barbara
    Liedl, Giovanni
    Cangioli, Elisabetta
    Grifoni, Stefano
    Jimenez, David
    INTERNAL AND EMERGENCY MEDICINE, 2017, 12 (05) : 657 - 665
12345